4月1日，英诺特获华安证券买入评级，近一个月英诺特获得3份研报关注。
研报预计公司2023-2025年营业收入有望实现4.78/8.02/11.36亿元，同比增长7.0%/67.8%/41.7%；归母净利润实现1.75/3.96/5.69亿元，同比增长15.9%/126.8%/43.7%。研报认为，公司作为呼吸道病原体POCT检测龙头，24Q1收入、利润增速超预期，业绩持续性逐渐显现。
风险提示：产品研发进度不及预期、国际化不达预期、市场竞争加剧风险。
- Headlines
- 英诺特获华安证券买入评级，24Q1核心收入同比增长250%
英诺特获华安证券买入评级，24Q1核心收入同比增长250%
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Hot News
Updated
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.